OPC Pharmaceutical Joint Stock Company

HOSE:OPC Stock Report

Market Cap: ₫1.5t

OPC Pharmaceutical Valuation

Is OPC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OPC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OPC (₫23000) is trading above our estimate of fair value (₫5317.74)

Significantly Below Fair Value: OPC is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OPC?

Key metric: As OPC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OPC. This is calculated by dividing OPC's market cap by their current earnings.
What is OPC's PE Ratio?
PE Ratio17.1x
Earnings₫86.16b
Market Cap₫1.49t

Price to Earnings Ratio vs Peers

How does OPC's PE Ratio compare to its peers?

The above table shows the PE ratio for OPC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18x
DP3 Central Pharmaceutical No3
10.4xn/a₫1.2t
PMC Pharmedic Pharmaceutical Medicinal
15.8xn/a₫1.0t
DMC Domesco Medical Import - Export
14.8xn/a₫2.3t
DCL Cuu Long Pharmaceutical
30.8xn/a₫2.0t
OPC OPC Pharmaceutical
17.1xn/a₫1.5t

Price-To-Earnings vs Peers: OPC is good value based on its Price-To-Earnings Ratio (17.1x) compared to the peer average (18x).


Price to Earnings Ratio vs Industry

How does OPC's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?

12 CompaniesPrice / EarningsEstimated GrowthMarket Cap
OPC 17.1xIndustry Avg. 24.6xNo. of Companies74PE020406080100+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OPC is good value based on its Price-To-Earnings Ratio (17.1x) compared to the Asian Pharmaceuticals industry average (24.6x).


Price to Earnings Ratio vs Fair Ratio

What is OPC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OPC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OPC's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies